Measles Initiative Management and Financing September 13, 2011.

Slides:



Advertisements
Similar presentations
Diseases without borders What must the Global Development Community Do? World Bank Seminar Series Tawhid Nawaz, Operations Advisor Human Development Network.
Advertisements

The Effectiveness of Global Health Partnerships Findings and Lessons from a World Bank Evaluation of Global Health Programs Uma Lele April 14, 2005.
Global Measles and Rubella Strategic Plan
Building Statistical Capacity To Monitor Development Progress World Bank Development Data Group.
UN Channels and Mechanisms for Development Cooperation and the Role of Emerging Donors Cheile Gradistei, 18 September 2008 Daniel Hanspach Emerging Donors.
Bank Group Engagement in Extractive Industries (EI) Presentation by Tove STRAUSS Governance Division (OSGE.1) African Development Bank Tunis, TUNISIA.
Overview of the Global Fund: Guiding Principles Grant Cycle / Processes & Role of Public Private Partnerships Johannesburg, South Africa Tatjana Peterson,
Working Together to Improve Global Health
A global partnership to stop measles & rubella The Measles & Rubella Initiative: Preparing for the Next Decade Lisa Cairns, MD, MPH Sept 18, 2012 Washington,
RBM Communications Assessment Challenges and Opportunities in Ghana, Mali, Senegal, Tanzania and Uganda.
1 Collective Efficiencies Development Finance Architecture Workshop Prerna Banati - July
Global Measles and Rubella Management Meeting Progress and Challenges in Bangladesh March, 2011 Geneva, WHO HQ Dr Serguei Diorditsa.
Measles Initiative Financing February 28, 2007 Washington, D.C. Andrea Gay UN Foundation for Measles Partners.
Regional Centers for Results Based Management and Evaluation Capacity Development: Regional Centers for Results Based Management and Evaluation Capacity.
THE ROLE OF STOP TB GHANA PARTNERSHIP Chief Austin A. Obiefuna National Coordinator SECRETARIAT CO-HOSTED BY AFRO GLOBAL ALLIANCE (GH) & GHANA SOCIETY.
National Malaria Program Scale-up for Advocacy Based on Impact 23 January 2006.
The Measles Initiative American Red Cross IFRC World Youth Meeting 2009.
Meningitis Vaccine Procurement. Meningitis belt countries in Africa.
The Global Fund- structure, function and evolution February 18, 2008.
Lessons from Ethiopia’s Productive Safety Net Programme & Aid Effectiveness.
Accelerated Measles Mortality Reduction Improving Routine Immunization in Africa (AMMRIRIA) - Update Alan Hinman & Samantha Kluglein September 14, 2011.
IMMUNIZATION IN UGANDA Dan Wamanya IMMUNIZATION IN UGANDA Dan Wamanya USAID/Uganda.
Keeping promises, Measuring results: The Global Strategy and Accountability for Women's and Children's Health Bernadette Daelmans Family, Women and Children's.
Edward J. Hoekstra, MD, MSc Edward J. Hoekstra, MD, MSc Senior Health Advisor Senior Health Advisor UNICEF HQ, New York UNICEF HQ, New York Peter Strebel,
MEASLES MORTALITY REDUCTION IN INDIA Status and Future Plans.
April_2010 Partnering initiatives at country level Proposed partnering process to build a national stop tuberculosis (TB) partnership.
JAHSR TECHNICAL REVIEW MEETING EPI Report Dr Dafrossa C Lyimo Programme Manager 7th September 2010 Dar es salaam.
1 1 Bose: SEAR Highlights and Priorities Global Measles & Rubella Management Meeting Geneva, March 2011 Accelerated Measles Control: Highlights and.
Funding Update: 2013 – 2015 September 10,
Funding Update GMMM March 21, 2012 Andrea Gay, UNF Athalia Christie, ARC Rebecca Martin, CDC 1.
MEASLES AND RUBELLA INITIATIVE Presentation by : Sylvia Khamati. Health Advisor Kenya Red Cross Society “Story from the Field” 15 th September 2015 American.
The Global Fund and Southern Africa A review of the structures and grants in southern Africa.
Global Overview of Measles & Rubella 11 th Annual Meeting The Measles Initiative Washington, DC th September, 2012.
1 |1 | Measles pre-elimination and resurgence in the African region Balcha Masresha IVD AFRO Global Measles Management Meeting Geneva March 2011.
World Health Organization "3 by 5" Target Treat 3 million by 2005.
WHO EURO In Country Coordination and Strengthening National Interagency Coordinating Committees.
Efficiency ׀ Transparency ׀ Accountability Multi-Donor Trust Fund Office Fund Management for Development Assistance UN-REDD Programme Policy Board Panama,
2011 Progress Report Grant Cameron Development Data Group, World Bank April 2011.
External Relations and Partnerships Harmonization and Coordination Experiences of the Global Fund.
Sudan EPI Benefits From Polio Eradication Program M&RI Annual Partners Meetings Washington D.C September 2015 Sudan EPI Benefits From Polio Eradication.
Update on Progress toward Measles Situation in EMR September 2008 Dr B. Naouri VPI/DCD/EMRO.
INNOVATIVE FINANCE: HELPING SAVE MORE LIVES Paolo Sison Director, Innovative Finance Tbilisi International Solidarity and Innovative Financing.
Belgrade, Donor Coordination Meeting Belgrade, 4 th of June 2012.
Simplification and Harmonization - Update UNDAF results matrix: feed back from roll out countries Joint Programming.
UNGEI – GPE Partnership Questions for UNGEI GAC. UNGEI Resources What resources might be required at the global or country level to carry out the proposed.
HIV/AIDS A MAJOR DEVELOPMENT CONCERN FOR THE AFRICAN DEVELOPMENT BANK March 2008.
IASC Task Team on Accountability to Affected Populations and Protection from sexual Exploitation and Abuse (AAP/PSEA) What should happen with the TT after.
UPDATE ON GAVI ALLIANCE, THE GLOBAL FUND AND WORLD BANK COLLABORATIVE EFFORT FOR MORE EFFECTIVE HSS SEPTEMBER, 2009 Exploring a potential common platform.
The Bank’s Regional HIV/AIDS Strategies An Overview.
Measles Mortality Reduction: the risk of resurgence Global Immunization Meeting Geneva, Switzerland 1-3 February 2010 Balcha Masresha, WHO/AFRO.
A global partnership to stop measles & rubella 1 Measles & Rubella Initiative --Who We Are-- Stephen Cochi, MD, MPH Global Immunization Division Centers.
12 th Annual Meeting of The Measles & Rubella Initiative American Red Cross, Washington, DC September, 2013.
Measles and Rubella Initiative Financial Resource Requirements for Measles and Rubella Annual Partners Meeting, September
Fifteenth Board Meeting Geneva, April 2007 Partners in Impact Results Report Global Fund Board Meeting Geneva, April 2007.
Global Measles and Rubella: Highlights, Priorities and Critical Issues
An Overview of the Global Fund and its Architecture
Global Overview of Measles
World Health Organization
Measles Containing Vaccines
Measles & Rubella Initiative Partners meeting September 7-8, 2017
Joint session with IHP+ introduction
Stakeholder Consultation
Experience with the measles outbreak response fund
Joint PBF / MPTF Office initiatives and Financial Update
Funding Update: Current Situation and Future Prospects
State of Measles Initiative Financing Partners for Measles Advocacy Meeting Washington, D.C. September 22, 2008 Andrea Gay.
The Global Fund to Fight AIDS, Tuberculosis and Malaria
Partners for Measles Advocacy—7th Annual Meeting
E-PRESS: a partner planning tool on support to statistics
Mobilizing Resources through Programmatic Approaches
Presentation transcript:

Measles Initiative Management and Financing September 13, 2011

Overview MI management and finance mechanism –strengths and challenges Financial update

MI Process Annual country plans Disbursement Management

Management - Strengths Country driven No secretariat Flexible Transparent Defined roles and responsibilities: with shared responsibility and credit Well coordinated: avoids programme fragmentation Clearly defined monitoring and evaluation indicators and process Accountable: accurate & detailed reporting of results & resources on annual basis

Management Balance needs of each partner agency with needs of the MI MI communication/advocacy support hired MI branded communication tools –MI.org, Facebook, Twitter, Storify, etc. ChallengeTactic

Management Raise awareness of partnership and goals Advocacy survey –Inform direction of MI advocacy team MI advocacy team (MIAT) –Finalizing TORs, structure and management, short-term workplan ChallengeTactic

“The Measles Fund” Financial Mechanism ARCCDC UNF (matching funds) UNFIP WHO/HQUNICEF/NYUNICEF/Supply WHO/CountryUNICEF/Country MOH, Red Cross/Crescent Societies, Lions, LDS and other NGOsICC (Donor Partners) (UN Partners) (In-Country Partners) Operational Costs, Technical Assistance, and Lab/Surveillance Country Plans Vaccine/ Syringes Country Plans Note: Funds are released when ICC-approved country plans are approved by partners. Other Donors

Financial Mechanism - Strengths Flexible Rapid and full disbursement of funds Able to balance WHO and UNICEF funding needs in different settings Low overhead costs Low transaction costs for donors, partners and countries (one pooled donor fund, one proposal, one report) Streamlined: joint resource mobilization

Financial Mechanism Decline in funds available Additional resource mobilization support –TORS developed, interviews underway New partners Measles mortality reduction investment case (Dec. 2011) Eradication investment case (Apr. 2012) High net worth individuals investment case (near final) ChallengeTactic Measles Initiative Annual Donations, * *Excluding country contributions

Financial Mechanism Large outbreaks that require emergency ORI –$30m in 2010 and in 2011 Sufficient funds for high quality preventative campaigns Ongoing discussions regarding outbreak response fund Coordination with other humanitarian agencies ChallengeTactic Measles Case Distribution by Month, Sub-Saharan Africa

Financial Mechanism Non-binding agreement with countries to finance 50% of SIA costs On-going discussions with GAVI and other partners to explore common standards for implementing country co-financing MI advocacy team to focus on raising political and financial commitment from implementing countries ChallengeTactic

Financial Update

Historic Measles Initiative Support Technical –Vaccination and surveillance strategies –Program planning, implementation, M and E Financial –Bundled vaccine –SIA operational costs 100% catch-up campaigns 50% for follow-up campaigns –Lab and surveillance –Technical assistance Advocacy and communication

Additional Cost Elements to Achieve Goals Research Outbreak response Routine –Scale up of MCV1 –MCV2 introduction Rubella –Catch-up campaigns –Introduction into routine

Funding Gap 2012: $43.4 million Annual Donations and Financial Resource Requirements, Projections, Funding Gap 2012 * Excluding country contributions

Total: $987 million (excluding country contributions for follow-up SIAs, & intro. of MCV2) *includes ARC and partners: ARC chapter contributions, Anne Ray Charitable Trust, BD, Herman and Katherine Peters Foundation, and others ** includes UNF and partners External Contributions, Projected Contributions and Funding Gap for funding gap US$43.4 m

Next Steps Financial resource requirements, Measles eradication investment case –global burden of disease –expected benefits, risks, and costs of the eradication and comparator options (i.e., control) –social, political, and economic challenges –ethical considerations –operational and other research needs –different financial instruments and funding mechanisms –options for management and governance

Anne Ray Charitable Trust